Saturday 17 October 2026 Export DCGO’s income statement to Excel — free account

DocGo Inc.

DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024. In the quarter to June 2026, revenue fell 8.70%, EPS fell 45.5%, free cash flow fell 132.3% and total debt rose 7,140.9%, each against the same quarter a year earlier.

0.27 0.01 −3.57%

Follow DCGO

Alert me

Market cap: $27.9M
P/E: 0.0×
Fwd P/E: −1.6×
Dividend yield: —
F-score: 3/9
Altman Z: −1.37
Beneish M: −8.29
Dividend safety: 45/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.02

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	1	—	—	—	—	—	—	—	—	—	—

Insider Ownership 6.34%

Capital & Financial Ratios $m

Market Cap 27.92

Revenue 294.72

Net Income (206.69)

Free Cash Flow (28.57)

Net Debt (25.07)

Current Ratio 1.66

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (1.62)

P/S ratio 0.09

P/B ratio 0.28

Past 5Y EPS Growth —

This Y EPS Growth 72.42%

Next Y EPS Growth 46.80%

Next Y revenue growth (4.87%)

Next 5Y EPS Growth 44.18%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.17%

10-year low 10-year high

P/B against its own 10 years 4.71%

10-year low 10-year high

EV/Sales against its own 10 years 0.17%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2022	Powerpack
2021	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	59	89	51	25
Receivables	262	211	93	86
Inventory	—	—	—	—
Other	—	0	4	4
	339	304	152	120

	2023	2024	2025	Q'26
Payables	20	28	11	14
ST’ Debt	—	—	—	—
Other	28	5	3	9
	170	122	67	72

Compound Annual Growth %

	10y	5y	3y
Sales	—	27.91%	(9.90%)
Cash Flow	—	0.00%	6.07%
Earnings	—	0.00%	0.00%
Book Value	—	13.46%	(23.30%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	76	73	—	—	—
’25	96	80	71	75	322
’24	192	165	139	121	617
’23	113	125	187	199	624
’22	118	110	104	109	441
’21	50	62	86	121	319

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(5)	(9)	—	—	—
’25	9	34	2	(10)	34
’24	(11)	37	31	13	70
’23	(23)	11	(46)	(6)	(64)
’22	18	12	7	(9)	29
’21	(1)	0	8	(9)	(2)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(6)	(10)	—	—	—
’25	8	32	0	(13)	27
’24	(12)	35	30	12	65
’23	(26)	9	(47)	(9)	(74)
’22	17	11	5	(10)	23
’21	(3)	(2)	7	(11)	(9)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.15)	(0.16)	—	—	—
’25	(0.09)	(0.11)	(0.28)	(1.37)	(1.84)
’24	0.10	0.06	0.05	(0.04)	0.18
’23	(0.03)	(0.02)	0.05	0.07	0.06
’22	0.09	0.11	0.03	0.09	0.34
’21	(0.03)	1.13	0.01	0.21	0.25

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	9.95	7.14	4.96	4.80	2.75	0.86	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	10.51	11.86	11.41	10.82	5.61	5.68
People
People	Employees	—	—	—	—	4	2,924	3,252	4,164	4,407	3,568
	Revenue/emp, $m	—	—	—	—	23.52	0.11	0.14	0.15	0.14	0.09
Income, $m
Income, $m	Revenue	—	—	—	—	94	319	441	624	617	322
	Gross margin, %	—	—	—	—	33.32	34.43	35.12	31.30	34.64	30.65
	EBT	—	—	—	—	(15)	20	23	16	28	(187)
	EBT margin, %	—	—	—	—	(15.55)	6.21	5.17	2.61	4.50	(58.19)
	Net income	—	0	—	—	(15)	19	31	10	13	(196)
	Depreciation	—	—	—	—	6	7	13	16	16	74
Per share, $
Per share, $	Revenue	—	—	—	—	1.61	3.97	4.35	6.03	6.02	3.25
	Earnings	—	—	—	—	(0.25)	0.30	0.34	0.07	0.20	(1.84)
	Cash flow	—	—	—	—	(0.18)	(0.02)	0.29	(0.62)	0.68	0.35
	Capex	—	—	—	—	(0.10)	(0.08)	(0.05)	(0.09)	(0.05)	(0.07)
	Free cash flow	—	—	—	—	(0.29)	(0.11)	0.23	(0.71)	0.63	0.27
	Book value	—	—	—	—	1.15	2.83	2.76	2.95	3.08	1.27
	Shares, m	—	—	—	—	58	80	101	104	102	99
Valuation, ×
Valuation, ×	P/E	—	—	—	—	0.00	7.10	20.53	73.86	22.32	0.00
	P/S	—	—	—	—	0.00	2.36	1.70	0.86	0.70	0.27
	P/B	—	—	—	—	2.18	3.31	2.68	1.75	1.38	0.69
	EV/Sales	—	—	—	—	0.00	1.81	1.34	0.76	0.56	0.11
	EV/FCF	—	—	—	—	0.00	(67.19)	25.33	(6.47)	5.32	1.34
Cash, $m
Cash, $m	Operating cash flow	—	—	—	—	(11)	(2)	29	(64)	70	34
	Capex	—	—	—	—	(6)	(7)	(5)	(9)	(5)	(7)
	Free cash flow	—	—	—	—	(17)	(9)	23	(74)	65	27
Balance, $m
Balance, $m	Working capital	—	—	—	—	35	198	171	169	183	85
	Total debt	—	—	—	—	1	1	1	0	0	0
	Net debt	—	—	—	—	(32)	(174)	(156)	(59)	(89)	(51)
	Shareholders’ equity	—	—	—	—	67	227	279	305	315	126
Returns, %
Returns, %	ROA	—	—	—	—	(28.67)	11.59	9.84	1.55	4.23	(54.23)
	ROIC	—	—	—	—	(26.26)	18.17	11.11	3.83	7.94	(148.29)
	ROE	—	—	—	—	(10.46)	16.15	13.67	2.35	6.45	(82.71)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
JYNT The Joint Corp.	$97.7M	26.0×	16.9×	+14.41% (above 0%: growing)	+400.00% (above 0%: growing)	+432.31% (above 0%: growing)	83.68%	(2.43%)	Compare
PARK Park Dental Partners, Inc.	$91.3M	— (loss-making)	—	+12.15% (above 0%: growing)	−65.84% (below 0%: shrinking)	−34.78% (below 0%: shrinking)	14.37%	1.90%	Compare
BTMD biote Corp.	$39.9M	6.8×	11.0×	−9.48% (below 0%: shrinking)	n/m	−174.16% (below 0%: shrinking)	65.38%	(7.93%)	Compare
PIII P3 Health Partners Inc.	$30.1M	— (loss-making)	—	+8.60% (above 0%: growing)	n/m	−272.24% (below 0%: shrinking)	22.26%	10.67%	Compare
CCEL Cryo-Cell International Inc.	$29.4M	— (loss-making)	43.8×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
DCGO DocGo Inc.	$27.9M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR	$15.9M	— (loss-making)	8.3×	+25,427.42% (above 0%: growing)	n/m	−206.36% (below 0%: shrinking)	42.70%	(1.24%)	Compare
CCM Concord Medical Services Holdings Limited	$10.5M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%	Compare
AMS American Shared Hospital Services	$8.4M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)	Compare
Median of peers	$29.7M	—	11.0×	+13.28%	+77.78%	−116.26%	32.48%	(0.62%)

All 55 Medical Care Facilities stocks →

DocGo Inc. (DCGO) key facts

Concern: DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024.
DocGo Inc. (DCGO) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, DCGO traded at $0.27, a market capitalization of $27.9 million.
Return on equity was −82.7% and debt-to-equity 0.00.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −1.37 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.